Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Steven Rosenberg

Concepts (595)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Neoplasm
57
2025
322
13.780
 Why?
Lymphocytes, Tumor-Infiltrating
62
2025
209
13.630
 Why?
Receptors, Antigen, T-Cell
55
2024
719
10.840
 Why?
Immunotherapy, Adoptive
53
2024
359
10.060
 Why?
T-Lymphocytes
47
2024
2003
7.150
 Why?
Melanoma
49
2024
792
6.950
 Why?
Neoplasms
35
2025
2718
5.210
 Why?
Gastrointestinal Neoplasms
8
2025
75
4.410
 Why?
CD8-Positive T-Lymphocytes
26
2023
915
3.800
 Why?
Autism Spectrum Disorder
22
2024
418
3.420
 Why?
Immunotherapy
16
2025
643
3.100
 Why?
Adoptive Transfer
18
2024
223
2.690
 Why?
Proto-Oncogene Proteins p21(ras)
8
2022
248
2.640
 Why?
Developmental Disabilities
13
2023
284
2.380
 Why?
Mutation
32
2025
3999
2.360
 Why?
Cancer Vaccines
8
2021
166
2.080
 Why?
Antigens, CD19
9
2022
137
1.990
 Why?
Programmed Cell Death 1 Receptor
9
2025
260
1.890
 Why?
CD4-Positive T-Lymphocytes
12
2022
1112
1.880
 Why?
Skin Neoplasms
13
2020
853
1.800
 Why?
Interleukin-2
7
2025
451
1.800
 Why?
Neoplasm Metastasis
18
2024
674
1.750
 Why?
Autistic Disorder
8
2024
210
1.690
 Why?
Humans
194
2025
140898
1.480
 Why?
ras Proteins
4
2021
145
1.420
 Why?
Colorectal Neoplasms
5
2025
805
1.340
 Why?
Neoplasm Proteins
7
2019
433
1.310
 Why?
Tumor Suppressor Protein p53
6
2022
526
1.250
 Why?
High-Throughput Nucleotide Sequencing
6
2025
544
1.220
 Why?
Epitopes, T-Lymphocyte
9
2021
183
1.180
 Why?
Eligibility Determination
3
2014
68
1.170
 Why?
Genetic Therapy
8
2022
315
1.130
 Why?
Membrane Proteins
9
2019
1156
1.060
 Why?
Lymphoma, B-Cell
4
2020
131
1.060
 Why?
Female
101
2025
75540
1.020
 Why?
Glioblastoma
2
2021
334
1.010
 Why?
Proto-Oncogene Proteins B-raf
4
2019
223
1.000
 Why?
Motor Skills Disorders
4
2016
29
0.980
 Why?
Child Development
7
2024
496
0.910
 Why?
Male
86
2025
69893
0.890
 Why?
Transcriptome
4
2022
1007
0.870
 Why?
Genetic Engineering
6
2016
92
0.870
 Why?
Middle Aged
56
2025
34487
0.860
 Why?
HLA-A2 Antigen
11
2020
48
0.860
 Why?
Gene Expression Regulation, Neoplastic
7
2019
1430
0.820
 Why?
Cell Line, Tumor
26
2021
3487
0.820
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2017
189
0.810
 Why?
Coronary Artery Disease
6
2017
702
0.800
 Why?
Flow Cytometry
9
2018
1195
0.790
 Why?
Precision Medicine
3
2015
433
0.780
 Why?
T-Lymphocyte Subsets
5
2019
414
0.760
 Why?
Ovarian Neoplasms
2
2019
580
0.740
 Why?
Medicare Part C
2
2013
31
0.740
 Why?
Tumor Microenvironment
2
2019
699
0.740
 Why?
Cell Separation
4
2019
317
0.720
 Why?
Single-Cell Analysis
3
2022
337
0.700
 Why?
Adult
46
2025
39134
0.700
 Why?
HLA-DP beta-Chains
3
2019
91
0.690
 Why?
Interleukin-12
3
2020
123
0.680
 Why?
Receptors, Antigen
3
2015
17
0.670
 Why?
Cognition Disorders
2
2016
513
0.650
 Why?
HLA-A Antigens
2
2021
57
0.640
 Why?
Receptors, Antigen, T-Cell, alpha-beta
4
2020
335
0.640
 Why?
Aged
35
2025
24666
0.640
 Why?
Hematopoietic Stem Cell Transplantation
3
2022
670
0.630
 Why?
Antigen Presentation
8
2020
219
0.630
 Why?
Retroviridae
2
2022
103
0.620
 Why?
Mutation, Missense
2
2020
340
0.610
 Why?
Colonic Neoplasms
2
2019
244
0.610
 Why?
Interleukin-15
2
2017
100
0.610
 Why?
Mucin-4
1
2019
4
0.600
 Why?
Smad5 Protein
1
2019
8
0.600
 Why?
Temperament
1
2019
45
0.590
 Why?
Lymphocyte Depletion
2
2016
136
0.590
 Why?
Exome
7
2016
238
0.590
 Why?
Immunity, Cellular
1
2020
267
0.590
 Why?
Child, Preschool
29
2024
11462
0.580
 Why?
T-Lymphocytes, Regulatory
2
2019
393
0.580
 Why?
Cholangiocarcinoma
2
2023
96
0.570
 Why?
Sequence Analysis, DNA
2
2021
817
0.560
 Why?
Bile Duct Neoplasms
2
2023
118
0.560
 Why?
ErbB Receptors
2
2019
608
0.560
 Why?
Disease Susceptibility
1
2019
352
0.530
 Why?
Family Characteristics
2
2018
191
0.520
 Why?
Genetic Vectors
5
2022
336
0.520
 Why?
Antigens
1
2019
361
0.510
 Why?
RNA, Messenger
3
2020
2822
0.510
 Why?
History, 20th Century
4
2025
325
0.510
 Why?
Child Behavior
1
2019
250
0.510
 Why?
Social Behavior
2
2023
287
0.500
 Why?
History, 21st Century
3
2025
218
0.500
 Why?
Awards and Prizes
1
2017
72
0.490
 Why?
Myocardial Perfusion Imaging
2
2013
49
0.490
 Why?
Transposases
1
2016
19
0.490
 Why?
Cell Engineering
1
2016
15
0.480
 Why?
Communication
2
2023
948
0.480
 Why?
Gene Expression Profiling
8
2019
1761
0.470
 Why?
Bile Ducts, Intrahepatic
2
2023
58
0.470
 Why?
Self-Injurious Behavior
4
2018
138
0.460
 Why?
Cell Cycle Checkpoints
1
2016
97
0.460
 Why?
Lymphoma
1
2017
228
0.460
 Why?
Psychotherapy
1
2017
184
0.460
 Why?
Immunologic Memory
5
2024
359
0.450
 Why?
Surveys and Questionnaires
9
2024
5931
0.430
 Why?
Breast Neoplasms
3
2022
2235
0.420
 Why?
T-Cell Antigen Receptor Specificity
7
2020
51
0.420
 Why?
Lymphocyte Transfusion
1
2013
21
0.410
 Why?
Lymphocytes
1
2016
394
0.410
 Why?
Lymphocyte Activation
10
2020
1141
0.410
 Why?
Sentinel Lymph Node Biopsy
1
2014
115
0.410
 Why?
Th1 Cells
1
2014
139
0.400
 Why?
Vidarabine
4
2017
35
0.400
 Why?
Plaque, Atherosclerotic
1
2014
58
0.400
 Why?
Leukemia
2
2016
243
0.400
 Why?
Lymph Node Excision
1
2014
169
0.390
 Why?
Histocompatibility Antigens Class I
5
2021
208
0.390
 Why?
Animals
29
2024
37579
0.390
 Why?
Indoles
1
2016
475
0.390
 Why?
Transplantation Conditioning
4
2019
184
0.390
 Why?
Cyclophosphamide
4
2017
256
0.380
 Why?
Child
22
2024
22313
0.380
 Why?
Melanoma, Experimental
4
2020
111
0.380
 Why?
Sulfonamides
1
2016
565
0.380
 Why?
Cell- and Tissue-Based Therapy
3
2019
85
0.370
 Why?
Stem Cell Transplantation
1
2013
187
0.370
 Why?
Transfection
1
2014
936
0.370
 Why?
Mice
21
2024
18057
0.360
 Why?
Gene Expression
7
2016
1490
0.360
 Why?
Genes, T-Cell Receptor
3
2022
9
0.360
 Why?
Melanoma-Specific Antigens
3
2016
5
0.350
 Why?
Antibodies, Monoclonal
3
2017
1471
0.340
 Why?
Adaptor Proteins, Signal Transducing
1
2014
438
0.340
 Why?
Biomarkers, Tumor
6
2019
1243
0.340
 Why?
Neoplasms, Second Primary
2
2022
99
0.340
 Why?
Coronary Angiography
5
2017
316
0.330
 Why?
Case-Control Studies
13
2024
3578
0.330
 Why?
Treatment Outcome
15
2021
11125
0.330
 Why?
Coculture Techniques
3
2021
244
0.330
 Why?
Lung Neoplasms
3
2022
2552
0.320
 Why?
United States
16
2025
15195
0.320
 Why?
Transplantation, Autologous
3
2022
280
0.320
 Why?
Papillomaviridae
3
2019
121
0.320
 Why?
Medicaid
1
2014
446
0.320
 Why?
gp100 Melanoma Antigen
5
2016
8
0.320
 Why?
Child Development Disorders, Pervasive
2
2024
62
0.310
 Why?
Kidney Neoplasms
1
2014
400
0.310
 Why?
Infant
11
2017
9790
0.300
 Why?
Papillomavirus Infections
3
2018
363
0.300
 Why?
Transduction, Genetic
4
2019
135
0.300
 Why?
Combined Modality Therapy
5
2021
1240
0.290
 Why?
Peptides
4
2020
979
0.290
 Why?
Human papillomavirus 16
3
2018
31
0.290
 Why?
Phenotype
6
2024
3172
0.290
 Why?
Repressor Proteins
3
2017
428
0.280
 Why?
Prospective Studies
8
2023
7749
0.280
 Why?
Intellectual Disability
3
2024
173
0.270
 Why?
Antigens, Differentiation, T-Lymphocyte
2
2020
97
0.270
 Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
3
2017
27
0.270
 Why?
Cells, Cultured
8
2021
4199
0.260
 Why?
Algorithms
3
2015
1763
0.260
 Why?
Prevalence
8
2018
2780
0.260
 Why?
Carcinoma, Squamous Cell
3
2017
640
0.260
 Why?
Dendritic Cells
4
2019
502
0.260
 Why?
Neoplasm Staging
5
2018
1396
0.250
 Why?
Oncogene Proteins, Viral
2
2017
22
0.250
 Why?
Lymphocyte Count
2
2016
167
0.250
 Why?
Cell Proliferation
8
2019
2497
0.240
 Why?
Tomography, X-Ray Computed
6
2018
2760
0.240
 Why?
Uterine Cervical Neoplasms
4
2018
267
0.240
 Why?
CD8 Antigens
2
2018
76
0.240
 Why?
Young Adult
13
2020
13646
0.240
 Why?
Antigens, CD
3
2020
544
0.240
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2014
1786
0.240
 Why?
Carcinoma
2
2018
230
0.230
 Why?
National Cancer Institute (U.S.)
1
2025
48
0.230
 Why?
Tumor Cells, Cultured
5
2018
956
0.230
 Why?
Whole-Body Irradiation
2
2016
78
0.220
 Why?
Pilot Projects
5
2019
1815
0.220
 Why?
Brain Neoplasms
4
2018
1275
0.220
 Why?
Socioeconomic Factors
3
2018
1310
0.220
 Why?
DNA Transposable Elements
2
2016
120
0.220
 Why?
T-Lymphocytes, Cytotoxic
2
2015
173
0.210
 Why?
Longitudinal Studies
5
2016
2920
0.210
 Why?
Jaundice, Neonatal
1
2023
8
0.210
 Why?
Sensitivity and Specificity
3
2018
1968
0.210
 Why?
Adolescent
13
2023
22027
0.210
 Why?
Immunohistochemistry
4
2016
1726
0.210
 Why?
Disability Evaluation
3
2014
303
0.200
 Why?
Leukocytes, Mononuclear
3
2015
572
0.200
 Why?
Infant, Very Low Birth Weight
2
2014
70
0.200
 Why?
Protein Engineering
2
2014
109
0.200
 Why?
Problem Behavior
2
2022
104
0.200
 Why?
Proto-Oncogene Proteins
2
2017
624
0.190
 Why?
Parks, Recreational
1
2022
11
0.190
 Why?
Constriction, Pathologic
2
2014
240
0.190
 Why?
Time-to-Treatment
1
2024
223
0.190
 Why?
DNA-Binding Proteins
3
2019
1478
0.180
 Why?
Occupational Therapy
2
2014
97
0.180
 Why?
Proteasome Endopeptidase Complex
2
2020
159
0.180
 Why?
HEK293 Cells
5
2017
737
0.180
 Why?
Burkitt Lymphoma
1
2022
63
0.180
 Why?
Clone Cells
2
2019
267
0.180
 Why?
Amino Acid Sequence
4
2020
2152
0.180
 Why?
Sex Factors
4
2017
2051
0.180
 Why?
Biomarkers
3
2019
4175
0.180
 Why?
Oncogenes
2
2020
118
0.180
 Why?
Adaptation, Psychological
2
2024
678
0.180
 Why?
Exercise Test
2
2015
623
0.170
 Why?
Genes, Tumor Suppressor
2
2019
84
0.170
 Why?
Genes, T-Cell Receptor alpha
1
2021
12
0.170
 Why?
Apyrase
1
2020
24
0.170
 Why?
Gene Expression Regulation
3
2019
2604
0.170
 Why?
Demography
3
2018
295
0.170
 Why?
Cytokines
6
2022
2092
0.170
 Why?
Lectins, C-Type
1
2020
63
0.170
 Why?
Epitope Mapping
2
2018
61
0.170
 Why?
HLA Antigens
2
2021
234
0.170
 Why?
Oncolytic Virotherapy
1
2020
14
0.170
 Why?
MART-1 Antigen
3
2014
12
0.170
 Why?
Pancreatic Neoplasms
2
2022
889
0.170
 Why?
Multiple Myeloma
1
2023
282
0.160
 Why?
Psychotropic Drugs
1
2021
74
0.160
 Why?
Mice, Mutant Strains
1
2020
306
0.160
 Why?
Physical Therapy Modalities
2
2014
318
0.160
 Why?
Models, Immunological
1
2020
101
0.160
 Why?
Lymphatic Metastasis
2
2019
326
0.160
 Why?
Drug Utilization
1
2021
166
0.160
 Why?
HLA-C Antigens
2
2020
38
0.160
 Why?
Metastasectomy
2
2017
20
0.160
 Why?
Protein Binding
8
2020
2238
0.160
 Why?
Follow-Up Studies
7
2020
5194
0.160
 Why?
Premature Birth
1
2023
363
0.160
 Why?
Remission Induction
5
2020
309
0.160
 Why?
Amino Acid Substitution
1
2020
309
0.160
 Why?
Virus Replication
1
2022
531
0.150
 Why?
Gene Regulatory Networks
1
2022
310
0.150
 Why?
Age Factors
3
2024
3278
0.150
 Why?
Neoplasm Recurrence, Local
2
2017
1067
0.150
 Why?
Genes, Neoplasm
1
2019
22
0.150
 Why?
Cysteine
1
2020
208
0.150
 Why?
Antibodies, Monoclonal, Humanized
1
2025
908
0.150
 Why?
Alcohol Oxidoreductases
1
2019
61
0.150
 Why?
Neoplasms, Glandular and Epithelial
1
2019
50
0.150
 Why?
Gestational Age
2
2024
952
0.140
 Why?
Prognosis
6
2020
4060
0.140
 Why?
Practice Patterns, Physicians'
2
2021
1328
0.140
 Why?
Area Under Curve
3
2014
323
0.140
 Why?
Cell Line
4
2022
2879
0.140
 Why?
Referral and Consultation
4
2023
794
0.140
 Why?
Neoplastic Cells, Circulating
1
2019
76
0.140
 Why?
B-Lymphocytes
3
2020
857
0.140
 Why?
Trees
1
2018
69
0.140
 Why?
RGS Proteins
1
2018
17
0.140
 Why?
Cohort Studies
6
2016
5789
0.140
 Why?
Behavior Therapy
1
2021
282
0.140
 Why?
Smoking
2
2018
1573
0.140
 Why?
Ubiquitin Thiolesterase
1
2018
60
0.140
 Why?
Forkhead Transcription Factors
1
2019
200
0.140
 Why?
Education, Special
1
2017
24
0.140
 Why?
Medical Oncology
1
2020
316
0.140
 Why?
Mothers
1
2024
777
0.140
 Why?
Psychometrics
2
2019
734
0.130
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 14
1
2017
3
0.130
 Why?
Parents
4
2022
1440
0.130
 Why?
Hematologic Neoplasms
1
2019
159
0.130
 Why?
Uveal Neoplasms
1
2017
14
0.130
 Why?
Self-Examination
1
2017
2
0.130
 Why?
Recombinant Fusion Proteins
3
2015
672
0.130
 Why?
Societies, Scientific
1
2017
50
0.130
 Why?
Lymphoma, Non-Hodgkin
1
2018
123
0.130
 Why?
Maternal Age
1
2017
128
0.130
 Why?
Interferon-gamma
5
2020
789
0.130
 Why?
Immunologic Surveillance
1
2017
26
0.130
 Why?
Signal Transduction
5
2019
5148
0.130
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2017
174
0.130
 Why?
ROC Curve
3
2013
589
0.130
 Why?
Carcinogenesis
1
2018
215
0.130
 Why?
Administration, Intravenous
1
2017
161
0.130
 Why?
Population Surveillance
2
2017
479
0.130
 Why?
Tissue and Organ Procurement
1
2020
317
0.130
 Why?
fas Receptor
2
2015
97
0.130
 Why?
Disease Progression
5
2017
2791
0.130
 Why?
Sialadenitis
1
2016
2
0.120
 Why?
CTLA-4 Antigen
1
2017
102
0.120
 Why?
WT1 Proteins
1
2016
13
0.120
 Why?
Peptidomimetics
1
2016
4
0.120
 Why?
Circulating Tumor DNA
1
2016
35
0.120
 Why?
Mitogen-Activated Protein Kinases
1
2017
315
0.120
 Why?
Logistic Models
4
2016
2088
0.120
 Why?
Antineoplastic Agents
2
2017
2156
0.120
 Why?
Green Fluorescent Proteins
2
2015
401
0.120
 Why?
Urinary Bladder Neoplasms
1
2019
255
0.120
 Why?
HLA-DQ beta-Chains
1
2016
62
0.120
 Why?
ras GTPase-Activating Proteins
1
2015
15
0.120
 Why?
Immunoglobulin M
1
2017
287
0.120
 Why?
Immunoglobulin A
1
2017
214
0.120
 Why?
Transplantation Chimera
1
2016
59
0.120
 Why?
Immunodominant Epitopes
1
2015
27
0.120
 Why?
Clonal Evolution
1
2016
45
0.120
 Why?
Coronary Vessels
2
2017
247
0.120
 Why?
Peer Group
1
2018
247
0.120
 Why?
Proto-Oncogene Proteins c-akt
2
2015
442
0.120
 Why?
Molecular Targeted Therapy
1
2019
418
0.120
 Why?
Psychoanalytic Therapy
1
1995
14
0.120
 Why?
T-Lymphocytes, Helper-Inducer
1
2016
136
0.120
 Why?
RNA, Neoplasm
1
2015
79
0.120
 Why?
Receptors, HIV
1
2015
25
0.120
 Why?
Epitopes
2
2015
477
0.120
 Why?
Cesarean Section
1
2017
213
0.120
 Why?
Aged, 80 and over
3
2025
7899
0.110
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2016
75
0.110
 Why?
Zinc Fingers
1
2015
50
0.110
 Why?
Psychotherapy, Brief
1
1995
39
0.110
 Why?
Alphapapillomavirus
1
2015
36
0.110
 Why?
Odds Ratio
2
2014
1054
0.110
 Why?
Sarcoma, Synovial
1
2014
20
0.110
 Why?
Neoplasms, Germ Cell and Embryonal
1
2016
77
0.110
 Why?
Immunophenotyping
1
2016
327
0.110
 Why?
Immunity, Active
1
2014
11
0.110
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
2014
10
0.110
 Why?
Language
1
2018
309
0.110
 Why?
Psychotherapy, Group
1
1995
74
0.110
 Why?
Aspirin
1
2018
384
0.110
 Why?
Endoribonucleases
1
2015
79
0.110
 Why?
Metalloproteins
1
2014
6
0.110
 Why?
Managed Care Programs
1
1995
140
0.110
 Why?
Clinical Trials as Topic
5
2020
1031
0.110
 Why?
Triple Negative Breast Neoplasms
1
2017
199
0.110
 Why?
Clinical Trials, Phase II as Topic
1
2014
75
0.110
 Why?
Hepatitis A Virus Cellular Receptor 2
1
2014
30
0.110
 Why?
5' Untranslated Regions
1
2014
59
0.110
 Why?
Nitric Oxide Synthase Type I
1
2014
29
0.110
 Why?
Thrombotic Microangiopathies
1
2014
20
0.110
 Why?
Echocardiography, Stress
1
2013
24
0.100
 Why?
Ribosomal Proteins
1
2014
92
0.100
 Why?
Tumor Lysis Syndrome
1
2013
8
0.100
 Why?
MAP Kinase Kinase Kinase 5
1
2013
7
0.100
 Why?
Policy Making
1
2014
79
0.100
 Why?
Transcription Factors
2
2019
1703
0.100
 Why?
Mice, Transgenic
5
2020
2176
0.100
 Why?
Autografts
1
2013
50
0.100
 Why?
Thioredoxins
1
2013
31
0.100
 Why?
HLA-DR4 Antigen
1
2013
77
0.100
 Why?
Testis
1
2014
158
0.100
 Why?
Extremities
1
2014
139
0.100
 Why?
Motor Skills
1
2014
103
0.100
 Why?
Carcinoma, Non-Small-Cell Lung
1
2022
1125
0.100
 Why?
Health Care Reform
1
2014
109
0.100
 Why?
Cross-Sectional Studies
5
2017
5645
0.100
 Why?
Gene Expression Regulation, Enzymologic
1
2014
270
0.100
 Why?
Immunoglobulin G
1
2017
897
0.100
 Why?
Psychiatric Status Rating Scales
1
2015
552
0.100
 Why?
Interferon-alpha
1
2014
196
0.100
 Why?
Transcriptional Activation
1
2015
377
0.100
 Why?
Astrocytoma
1
2013
130
0.100
 Why?
Histones
1
2018
638
0.100
 Why?
Allografts
1
2013
147
0.100
 Why?
Cognition
2
2023
1220
0.100
 Why?
Nuclear Proteins
2
2015
716
0.100
 Why?
Cell Movement
4
2019
982
0.100
 Why?
Likelihood Functions
1
2013
145
0.100
 Why?
Radiation Injuries
1
2014
147
0.100
 Why?
Nanotechnology
1
2013
124
0.090
 Why?
Receptors, N-Methyl-D-Aspartate
1
2014
226
0.090
 Why?
Survival Rate
4
2020
1962
0.090
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
236
0.090
 Why?
Infant, Newborn
4
2023
6257
0.090
 Why?
Esophageal Neoplasms
1
2016
336
0.090
 Why?
Risk Factors
5
2023
10430
0.090
 Why?
Calcinosis
1
2014
238
0.090
 Why?
Muscle Proteins
1
2013
236
0.090
 Why?
Sarcoma
1
2014
184
0.090
 Why?
Cost of Illness
1
2014
310
0.090
 Why?
Risk Assessment
3
2019
3484
0.090
 Why?
Propensity Score
1
2013
332
0.090
 Why?
Killer Cells, Natural
1
2014
467
0.090
 Why?
Prostatic Neoplasms
1
2019
1046
0.090
 Why?
Research Design
2
2014
1104
0.090
 Why?
Genome, Human
1
2013
421
0.080
 Why?
Head and Neck Neoplasms
1
2016
553
0.080
 Why?
Health Policy
1
2014
380
0.080
 Why?
Anxiety
1
2018
1076
0.080
 Why?
Randomized Controlled Trials as Topic
2
2013
1598
0.080
 Why?
Cytotoxicity, Immunologic
3
2016
224
0.080
 Why?
Xenograft Model Antitumor Assays
3
2020
903
0.080
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2014
985
0.080
 Why?
Genetic Testing
1
2013
463
0.080
 Why?
RNA-Binding Proteins
1
2014
447
0.080
 Why?
Wounds and Injuries
1
2018
896
0.080
 Why?
Decision Support Techniques
1
2013
429
0.080
 Why?
Models, Theoretical
1
2013
580
0.080
 Why?
K562 Cells
2
2020
95
0.070
 Why?
Time Factors
2
2017
6944
0.070
 Why?
HIV-1
1
2015
880
0.070
 Why?
Real-Time Polymerase Chain Reaction
3
2015
344
0.070
 Why?
Adenocarcinoma
1
2016
895
0.070
 Why?
Databases, Factual
3
2023
1441
0.070
 Why?
Protein Kinase Inhibitors
1
2014
917
0.070
 Why?
Coronary Stenosis
1
2008
38
0.070
 Why?
Colorado
2
2017
4597
0.070
 Why?
Arthritis, Rheumatoid
1
2017
1178
0.070
 Why?
RNA
1
2015
929
0.070
 Why?
Comorbidity
3
2018
1658
0.070
 Why?
Double-Blind Method
1
2013
1978
0.070
 Why?
Anti-HIV Agents
1
2015
846
0.070
 Why?
Apoptosis
2
2013
2571
0.070
 Why?
Neoplasm Transplantation
3
2015
250
0.070
 Why?
RNA, Small Interfering
3
2014
624
0.070
 Why?
Protective Factors
2
2017
96
0.060
 Why?
Neutrophils
1
2013
1282
0.060
 Why?
Faculty
1
2007
153
0.060
 Why?
Mass Screening
2
2020
1300
0.060
 Why?
DNA Mutational Analysis
2
2019
396
0.060
 Why?
Cross Reactions
2
2016
133
0.060
 Why?
Cardiovascular Diseases
1
2018
2082
0.060
 Why?
Molecular Sequence Data
3
2015
2917
0.060
 Why?
CD4 Antigens
2
2016
141
0.060
 Why?
Neutropenia
2
2017
154
0.060
 Why?
Mice, Inbred C57BL
4
2020
5895
0.060
 Why?
Mice, Inbred NOD
2
2018
599
0.060
 Why?
Single-Chain Antibodies
2
2015
17
0.050
 Why?
Protein Transport
2
2017
448
0.050
 Why?
Retrospective Studies
5
2024
16315
0.050
 Why?
Intercellular Junctions
2
2014
38
0.050
 Why?
Physical Examination
2
2017
242
0.050
 Why?
Parity
1
2024
110
0.050
 Why?
GPI-Linked Proteins
2
2014
78
0.050
 Why?
Nerve Tissue Proteins
2
2020
605
0.050
 Why?
Lung
1
2016
4127
0.050
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2023
27
0.050
 Why?
Exercise
1
2015
2108
0.050
 Why?
Point Mutation
2
2014
237
0.050
 Why?
Health Facilities
1
2023
82
0.050
 Why?
Autoantigens
2
2016
425
0.050
 Why?
Bone Marrow
1
2023
301
0.050
 Why?
Minority Groups
1
2024
277
0.050
 Why?
Receptors, Cell Surface
1
2004
398
0.050
 Why?
Cluster Analysis
2
2014
516
0.050
 Why?
Linear Models
1
2024
854
0.040
 Why?
Alleles
2
2015
883
0.040
 Why?
Skin
2
2019
764
0.040
 Why?
Oligonucleotide Array Sequence Analysis
2
2014
757
0.040
 Why?
Educational Status
1
2023
462
0.040
 Why?
Severity of Illness Index
2
2023
2898
0.040
 Why?
Recombinant Proteins
2
2014
1361
0.040
 Why?
Proportional Hazards Models
1
2024
1261
0.040
 Why?
Models, Genetic
2
2013
587
0.040
 Why?
Parenting
1
2024
319
0.040
 Why?
Jurkat Cells
1
2020
138
0.040
 Why?
Base Sequence
2
2014
2169
0.040
 Why?
Predictive Value of Tests
2
2017
2062
0.040
 Why?
Immunoglobulins
1
2020
167
0.040
 Why?
Cysteine Endopeptidases
1
2020
74
0.040
 Why?
Glioma
1
2004
418
0.040
 Why?
Early Diagnosis
1
2020
242
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2019
74
0.040
 Why?
Health Care Surveys
1
2021
562
0.040
 Why?
Hydrolysis
1
2019
196
0.040
 Why?
Fusion Regulatory Protein 1, Heavy Chain
1
2018
3
0.040
 Why?
GTP Phosphohydrolases
1
2019
93
0.040
 Why?
Caregivers
2
2018
940
0.040
 Why?
Uterine Cervical Dysplasia
1
2018
29
0.040
 Why?
GTP-Binding Protein alpha Subunits, Gi-Go
1
2018
18
0.030
 Why?
Forests
1
2018
60
0.030
 Why?
Protein Domains
1
2020
303
0.030
 Why?
Cervix Uteri
1
2018
51
0.030
 Why?
Nuclear Localization Signals
1
2017
18
0.030
 Why?
Neoplasm Grading
1
2019
309
0.030
 Why?
Mice, SCID
1
2018
365
0.030
 Why?
Disulfides
1
2018
99
0.030
 Why?
Hydrogen Bonding
1
2018
168
0.030
 Why?
Healthcare Disparities
1
2024
671
0.030
 Why?
Ligands
2
2013
667
0.030
 Why?
Platelet Aggregation
1
2018
112
0.030
 Why?
Human papillomavirus 18
1
2017
14
0.030
 Why?
Eye Enucleation
1
2017
15
0.030
 Why?
Response Evaluation Criteria in Solid Tumors
1
2017
18
0.030
 Why?
Protein Stability
1
2018
175
0.030
 Why?
GTP-Binding Protein alpha Subunits
1
2017
16
0.030
 Why?
GTP-Binding Protein alpha Subunits, Gq-G11
1
2017
20
0.030
 Why?
Culture Media, Serum-Free
1
2016
46
0.030
 Why?
Peptide Fragments
2
2015
698
0.030
 Why?
Lymphopenia
1
2017
67
0.030
 Why?
Binding Sites
1
2020
1315
0.030
 Why?
Vaccinia virus
1
2016
42
0.030
 Why?
Drug Synergism
1
2017
369
0.030
 Why?
Antigen-Presenting Cells
1
2017
159
0.030
 Why?
HLA-DRB1 Chains
1
2017
111
0.030
 Why?
Asymptomatic Diseases
1
2017
92
0.030
 Why?
Adenosine Triphosphate
1
2019
490
0.030
 Why?
Salivary Glands, Minor
1
2016
11
0.030
 Why?
Blood Chemical Analysis
1
2017
110
0.030
 Why?
Tissue Array Analysis
1
2016
51
0.030
 Why?
Health Surveys
1
2018
511
0.030
 Why?
Cell Membrane
1
2020
720
0.030
 Why?
Neoplasm Invasiveness
1
2018
508
0.030
 Why?
Leukemia, B-Cell
1
2016
13
0.030
 Why?
Radiotherapy
1
2017
202
0.030
 Why?
HLA-A1 Antigen
1
2015
4
0.030
 Why?
Fas Ligand Protein
1
2015
60
0.030
 Why?
Antigen-Antibody Reactions
1
2015
54
0.030
 Why?
Palate
1
2016
40
0.030
 Why?
Genes, erbB-2
1
2015
28
0.030
 Why?
MAP Kinase Signaling System
1
2017
324
0.030
 Why?
Salvage Therapy
1
2016
154
0.030
 Why?
Anemia
1
2017
176
0.030
 Why?
Feasibility Studies
1
2020
1022
0.030
 Why?
Interferon-gamma Release Tests
1
2015
33
0.030
 Why?
Anus Neoplasms
1
2015
33
0.030
 Why?
Health Promotion
1
2022
748
0.030
 Why?
Compulsive Behavior
1
2015
7
0.030
 Why?
Machine Learning
1
2021
554
0.030
 Why?
DNA, Neoplasm
1
2015
157
0.030
 Why?
Gastrointestinal Diseases
1
2017
206
0.030
 Why?
Necrosis
1
2016
247
0.030
 Why?
Cloning, Molecular
1
2016
532
0.030
 Why?
Thrombocytopenia
1
2017
207
0.030
 Why?
Coronary Occlusion
1
2015
20
0.030
 Why?
HIV Envelope Protein gp120
1
2015
61
0.030
 Why?
Dermatitis
1
2014
19
0.030
 Why?
HIV Antibodies
1
2015
63
0.030
 Why?
Income
1
2016
198
0.030
 Why?
Metabolic Clearance Rate
1
2014
116
0.030
 Why?
Regression Analysis
1
2017
1015
0.030
 Why?
Desmoplakins
1
2014
27
0.030
 Why?
Protein Conformation
1
2018
939
0.030
 Why?
Transplantation, Homologous
1
2016
415
0.030
 Why?
Monophenol Monooxygenase
1
2014
8
0.030
 Why?
Comparative Genomic Hybridization
1
2014
29
0.030
 Why?
Nausea
1
2014
111
0.030
 Why?
Cell Survival
1
2017
1129
0.030
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2015
159
0.030
 Why?
Models, Statistical
1
2018
667
0.030
 Why?
Mice, Inbred BALB C
1
2017
1271
0.030
 Why?
Gene Library
1
2014
119
0.030
 Why?
Random Allocation
1
2014
363
0.030
 Why?
National Institutes of Health (U.S.)
1
2014
132
0.030
 Why?
Social Class
1
2016
268
0.030
 Why?
MAP Kinase Kinase 4
1
2013
24
0.030
 Why?
Histocompatibility Antigens
1
2014
108
0.030
 Why?
Substrate Specificity
1
2014
384
0.030
 Why?
Infusions, Intravenous
1
2014
416
0.030
 Why?
Graft vs Host Disease
1
2016
256
0.030
 Why?
Tumor Burden
1
2014
310
0.030
 Why?
X-Ray Diffraction
1
2013
104
0.030
 Why?
Lentivirus
1
2013
59
0.030
 Why?
Confidence Intervals
1
2014
328
0.030
 Why?
Radiotherapy, Adjuvant
1
2014
217
0.030
 Why?
Sleep Wake Disorders
1
2017
304
0.030
 Why?
Immunoenzyme Techniques
1
2013
207
0.020
 Why?
Immunoprecipitation
1
2013
153
0.020
 Why?
Fever
1
2014
308
0.020
 Why?
Structure-Activity Relationship
1
2014
576
0.020
 Why?
Health Services Accessibility
1
2021
1020
0.020
 Why?
Reproducibility of Results
2
2012
3336
0.020
 Why?
Drug Administration Schedule
1
2014
766
0.020
 Why?
Bias
1
2013
208
0.020
 Why?
Models, Molecular
1
2018
1602
0.020
 Why?
Cotinine
1
2012
78
0.020
 Why?
DNA Primers
1
2013
508
0.020
 Why?
Histocompatibility Antigens Class II
1
2014
369
0.020
 Why?
Cost-Benefit Analysis
1
1995
609
0.020
 Why?
Receptors, Immunologic
1
2013
215
0.020
 Why?
Spleen
1
2014
522
0.020
 Why?
Bayes Theorem
1
2013
415
0.020
 Why?
Blotting, Western
1
2013
1231
0.020
 Why?
Pregnancy
1
2023
7035
0.020
 Why?
Diagnosis, Differential
1
2015
1491
0.020
 Why?
Liver Neoplasms
1
2017
740
0.020
 Why?
Multivariate Analysis
1
2014
1496
0.020
 Why?
Carrier Proteins
1
2014
746
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
2056
0.020
 Why?
Kinetics
1
2013
1651
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2015
1241
0.020
 Why?
Phosphorylation
1
2014
1758
0.020
 Why?
Infant, Premature
1
2014
598
0.020
 Why?
North Carolina
1
2008
120
0.020
 Why?
Germany
1
2008
131
0.020
 Why?
Self Report
1
2012
858
0.020
 Why?
Cell Differentiation
1
2015
1999
0.020
 Why?
Disease Models, Animal
1
2018
4407
0.020
 Why?
Vaccination
1
2016
1467
0.020
 Why?
Models, Biological
1
2014
1822
0.020
 Why?
MicroRNAs
1
2013
691
0.020
 Why?
Intelligence
1
2007
134
0.020
 Why?
Polymorphism, Single Nucleotide
1
2013
2128
0.010
 Why?
Receptors, Urokinase Plasminogen Activator
1
2004
15
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2004
30
0.010
 Why?
Transplantation, Heterologous
1
2004
193
0.010
 Why?
Species Specificity
1
2004
577
0.010
 Why?
Neovascularization, Pathologic
1
2004
295
0.010
 Why?
Mice, Nude
1
2004
689
0.010
 Why?
Down Syndrome
1
1987
505
0.010
 Why?
Polyethylene Glycols
1
2004
639
0.010
 Why?
Endothelium, Vascular
1
2004
949
0.010
 Why?
Rosenberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (595) concept(s)
_
Co-Authors Expand Description
See all (14) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)